Tsann‐Long Su

Statistics

Publications

Citations

835

H-Index

Active since

1971

Affiliations

Institute of Biomedical Sciences, Academia Sinica(Current)

Memorial Sloan Kettering Cancer Center

China Medical University

Institute of Cellular and Organismic Biology, Academia Sinica

Tsann‐Long Su is an author at Institute of Biomedical Sciences, Academia Sinica specializing in medicinal chemistry, pharmacology, and cancer pharmacology.

Publications per year

1971–2021

Publications

Terpyridine–platinum(II) complexes are effective inhibitors of mammalian topoisomerases and human thioredoxin reductase 1

Yan‐Chung Lo, Tzu‐Ping Ko, Wen‐Chi Su et al. · Journal of Inorganic Biochemistry · 2009 · 126 citations

Life Sciences, Medicinal Chemistry, Molecular Biology +12

Quantitative Autoradiographic Mapping of Herpes Simplex Virus Encephalitis with a Radiolabeled Antiviral Drug

Yutaka Saito, Richard W. Price, David A. Rottenberg et al. · Science · 1982 · 88 citations

Medicine, Pharmacology, Molecular Imaging +13

Potent DNA-directed alkylating agents: Synthesis and biological activity of phenyl N-mustard–quinoline conjugates having a urea or hydrazinecarboxamide linker

Rajesh Kakadiya, Huajin Dong, Amit Kumar et al. · Bioorganic & Medicinal Chemistry · 2010 · 52 citations

Pharmacy, Chemistry, Medicinal Chemistry +14

Distribution, metabolism, and excretion of 1-(2-fluoro-2-deoxy-beta-D- arabinofuranosyl)thymine and 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5- iodocytosine.

Frederick S. Philips, Aaron Feinberg, Ting‐Chao Chou et al. · PubMed · 1983 · 46 citations

Pharmacy, Pharmacokinetics, Pharmacology +7

Novel indolizino[8,7-b]indole hybrids as anti-small cell lung cancer agents: Regioselective modulation of topoisomerase II inhibitory and DNA crosslinking activities

Sue‐Ming Chang, Wilson Christian, Ming-Hsi Wu et al. · European Journal of Medicinal Chemistry · 2016 · 40 citations

Medicine, Medicinal Chemistry, Pharmacology +13

1–5 of 32